EyePoint Pharmaceuticals
EYPT
#8321
Rank
โ‚ฌ0.29 B
Marketcap
3,50ย โ‚ฌ
Share price
4.42%
Change (1 day)
-69.05%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -โ‚ฌ0.24 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ7.61 Million. In 2025 the company made an earning of -โ‚ฌ0.21 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.24 Billion14.33%
2025 -โ‚ฌ0.21 Billion63.24%
2024 -โ‚ฌ0.13 Billion104.29%
2023 -โ‚ฌ60.56 Million-29.88%
2022 -โ‚ฌ86.36 Million87.2%
2021 -โ‚ฌ46.13 Million38.58%
2020 -โ‚ฌ33.29 Million-24.56%
2019 -โ‚ฌ44.13 Million
2017 -โ‚ฌ20.13 Million22.59%
2016 -โ‚ฌ16.42 Million-8.02%
2015 -โ‚ฌ17.85 Million-296.09%
2014 โ‚ฌ9.1 M-174.02%
2013 -โ‚ฌ12.3 Million37.42%
2012 -โ‚ฌ8.95 Million-56.29%
2011 -โ‚ฌ20.47 Million-1062.38%
2010 โ‚ฌ2.12 M-250.43%
2009 -โ‚ฌ1.42 Million-89.5%
2008 -โ‚ฌ13.47 Million
2005 -โ‚ฌ8.31 Million56.99%
2004 -โ‚ฌ5.3 Million73.7%
2003 -โ‚ฌ3.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚ฌ1.89 Million-99.20% Bahamas
NRC Health
NRC
โ‚ฌ17.1 M-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA